Covetrus reports 2020 sales up 9%, shrinking loss

Portland-based Covetrus Inc. (Nasdaq: CVET) on Monday reported 2020 net sales of $4.3 billion, including $1.1 billion in the fourth-quarter — year-over-year increases of 9% and 11% respectively.

For the year, the animal-health company reported a loss of $19 million, or 22 cents per share, compared to $980 million, or $9.14 per share, in the previous year. During 2019, the company recorded a goodwill impairment charge of $939 million.

For the fourth quarter, Covetrus had a loss of $4 million, or 4 cents per share, compared to a loss of $37 million, or 33 cents per share, during Q4 2019. Read more

Related Posts

Maine’s first mobile biolab starts tour of rural schools in Fort Kent

FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...

12 March 2024

UMaine Augusta’s $1.75M medical lab training facility doubles student capacity

Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...

21 February 2024

UNE receives grant to research state-threatened animal

The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...

12 February 2024